Search - tctmd.com

Displaying 81 - 100 of 320

Sort: Relevancy | Date

Presentation TCT 2024

TCT 477: Procedural Outcomes in 25 Years of Alcohol Septal Ablations at a Tertiary Level Medical Center

Presenter: Nikhil Rao

October 27, 2024

Presentation TCT 2024

TCT 536: Impact of Hybrid Ablation and Surgical Closure of the Left Atrial Appendage on the Flow in the Left Atrium

Presenter: Brennan Vogl

October 27, 2024

Presentation ESC 2024

The SHAM-PVI Study: A randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation

Presenter: Rick Veasey

September 02, 2024

Presentation ESC 2024

The efficacy of low-voltage-area ablation in patients with persistent atrial fibrillation: Results from a SUPPRESS-AF trial

Presenter: Masaharu Masuda

September 02, 2024

Presentation ESC 2024

Stroke prevention & rhythm control Therapy: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation

Presenter: Dipak Kotecha

September 01, 2024

Presentation NY Valves 2024

Mitral TEER for Severe Mitral Regurgitation After VT Ablation With Ruptured Chord in a Patient With Previous Mitral Annuloplasty

Presenter: George Hanna

June 07, 2024

Presentation NY Valves 2024

Atrial FMR; Diagnosis and Therapy Choices (Including AF ablation)

Presenter: Jörg Hausleiter

June 05, 2024

Presentation NY Valves 2024

Adjunctive Ablation of Premature Ventricular Contractions During Mitral Valve Repair: How, When and Why?

Presenter: David H. Adams

June 05, 2024

Presentation NY Valves 2024

Case Presentation: Arrhythmic Mitral Valve Prolapse – Medication, Ablation, ICD or Surgery?

Presenter: Madison Edens

June 05, 2024

Presentation THT 2024

The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions

Presenter: Kevin Makati

March 05, 2024

Presentation THT 2024

PVC-Induced Cardiomyopathy: Ablation Is the Treatment of Choice

Presenter: William Hucker

March 05, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Randomized Trial 12-Month Results

Presenter: Sanjiv J. Shah

March 05, 2024

Presentation THT Abstracts 2024

Hemodynamic Response Related to Stimulation of the Greater Splanchnic Nerve Pre- and Post- Ablation

Presenter: Luke Kim

March 04, 2024

Presentation THT Abstracts 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Presenter: Sheldon Litwin

March 04, 2024

Presentation THT Abstracts 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis †

Presenter: Marat Fudim

March 04, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Presenter: Sheldon E. Litwin

March 04, 2024

Presentation THT 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis

Presenter: Marat Fudim

March 04, 2024

Presentation TCT 2023

TCT 528: Procedural Complications and Outcomes in Patients with Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myomectomy Versus Alcohol Septal Ablation.

Presenter: Ndausung Udongwo

October 26, 2023

Presentation TCT 2023

TCT 421: Permanent Pacemaker Following Alcohol Septal Ablation – Prevalence of Utilization at 1 Year?

Presenter: Michael Bashline

October 26, 2023

Presentation TCT 2023

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: One Year Results of the REBALANCE-HF Roll-in Cohort

Presenter: Sheldon Litwin

October 26, 2023

Advertisement

TCT 477: Procedural Outcomes in 25 Years of Alcohol Septal Ablations at a Tertiary Level Medical Center

TCT 536: Impact of Hybrid Ablation and Surgical Closure of the Left Atrial Appendage on the Flow in the Left Atrium

The SHAM-PVI Study: A randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation

The efficacy of low-voltage-area ablation in patients with persistent atrial fibrillation: Results from a SUPPRESS-AF trial

Stroke prevention & rhythm control Therapy: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation

Mitral TEER for Severe Mitral Regurgitation After VT Ablation With Ruptured Chord in a Patient With Previous Mitral Annuloplasty

Atrial FMR; Diagnosis and Therapy Choices (Including AF ablation)

Adjunctive Ablation of Premature Ventricular Contractions During Mitral Valve Repair: How, When and Why?

Case Presentation: Arrhythmic Mitral Valve Prolapse – Medication, Ablation, ICD or Surgery?

The Role of AF Ablation in HF Across the Spectrum of Ejection Fractions

PVC-Induced Cardiomyopathy: Ablation Is the Treatment of Choice

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Randomized Trial 12-Month Results

Hemodynamic Response Related to Stimulation of the Greater Splanchnic Nerve Pre- and Post- Ablation

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis †

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis

TCT 528: Procedural Complications and Outcomes in Patients with Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myomectomy Versus Alcohol Septal Ablation.

TCT 421: Permanent Pacemaker Following Alcohol Septal Ablation – Prevalence of Utilization at 1 Year?

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: One Year Results of the REBALANCE-HF Roll-in Cohort

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content